The BalancedInvestor Club

PAVM Market Analysis

Overview

Fundamentals

P/E ratio—
EPS (TTM)$-5.630.0% YoY
Profit margin565.0%HEALTHCARE
Market cap$62.0MMicro cap

Wall Street coverage

$40.50median target· current $65.70 (-38.4%)2 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
—
PEG ratio
0.00
P/B
6.58
P/S (TTM)
873.75
EV/EBITDA
25.79

Profitability & growth

ROE (TTM)
-32.3%
Operating margin
-13083.0%
Revenue growth YoY
420.0%
Dividend yield
—
Beta
0.64
Last earnings
Mar 30, 2026 · Estimate $-4.50 · Reported $-1.05
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About PAVmed Inc

PAVmed Inc. is a medical device company in the United States. The company is headquartered in New York, New York.

Classification

Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
360 MADISON AVENUE, NEW YORK, NY
Fiscal year end
December
Latest quarter
Dec 31, 2025
Market cap$62.0M
Shares outstanding$7.3M
52W high$24.07
52W low$6.00

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer